A safe dividend. Their legacy business is steady from Air Canada which sustains the dividend. 18 months ago, they moved into a growth area: leasing aircraft and are doing very well here with a big profit margin. The airline business continues to grow. They will likely raise the dividend.

Their development costs are low, and they pay a dividend. Rising oil prices is a tailwind. He recently bought it. Likes it.

If there's more drilling, then this and other oil service companies will do well. Rising oil prices will help.

An up and coming cannabis extraction in Canada. Once they receive their license, they will ramp up and process for growers. They're based near Vancouver, an area full of cannabis production companies who need their services. (no price target)

Their technology treats depression that's non-invasive. GTMS rolled out laser eye centres in the 1990s. They're growing in the U.S. rapidly. (Analysts’ price target is $6.00)

They started as a tradition grower, but are now building their extraction side where margins are high. Management has a great track record. (no target price)

Market. Most technical indicators he follows have seen a huge improvement since the lows on December 24th. He is waiting for economical data to accelerate to give him the all-clear. He is much closer to fully invested than before. He has moved from defensive back to offensive. Now we are seeing long term indicators that the uptrend is not just a recovery in a bear market but will push to higher highs. Due to sentiment indicators, he would not be surprised to see choppy trading through April.

It has been notching its way higher up. They continue to produce fairly good numbers. They used to be skewed to Canada and Energy and now they are diversified away from energy and away from Canada. He continues to like it. The one bad thing is consistent short seller reports of accounting problems but nothing ever comes out of it. Buy when a short seller comes out with a report.

He has owned it and it will be a Top Pick in the next couple of months. They have a massive discovery in gas. Some of their recent drilling results were not headline results but they are moving in the right direction. As they delineate the discovery, the share price will go higher until it is taken out by the partner.

It was a past pick of his. They signed some big brands out of the US. Once we get into extractive and concentrated products, and see some of the new products beyond dried flowers, oil and rolled products, this stock should take a step up. It could be an exciting year for them. He has been disappointed with the stock price but knows management will continue to move it forward.

He has had it as a past pick. This morning they came out with data. They have had a fantastic run rate. There is a valuation discrepancy. They will acquisitive. They just opened up a dispensary and traffic numbers are higher than they expected. They will have more repeat customers and more loyalty than a Las Vegas store.

Looking macro, technical indicators have all improved. We've seen higher trading in China. The city economic surprise index is about as low as we have ever seen it. Technically it is about to turn. He owns some of their competitors. You'll need a good stop loss on this one. (Analysts’ price target is $38.00)

It has had such a big move over 18 months. It is still quite solid. Technical tools suggested about 10 days ago he should reduce gold holdings and this was one of those. If you are a long term investor then the ups and downs should not concern you. You could step into this one right now.

It is growing exponentially but not at a point where they are growing profitability at that rate. He has looked at it and is interested in it. It is new.

CURELF-N vs. CL-X. He really made a focus on the US for cannabis. He thinks the US MSOs have a tremendous amount of room to go. CURELF-N is one of the leaders. CL-X just did a deal in California, which is one of the biggest markets out there. He likes both of them. They are both leaders.